Overview
The aim of this clinical trial is to determine if cerebello-spinal direct current stimulation (csDCS) is effective in treating gait disorders in individuals with chronic stroke. Additionally, the trial seeks to evaluate the safety of this technique.
The primary objectives include:
Investigating whether cerebello-spinal direct current stimulation improves gait and functional mobility in participants with chronic stroke.
Assessing any potential side effects associated with the method.
Researchers will conduct a comparative analysis between cerebello-spinal direct current stimulation and a sham procedure (which mimics the stimulation without any actual effect) to assess its effectiveness in addressing gait disorders and enhancing mobility.
Participants in the trial will:
Undergo cerebello-spinal direct current stimulation combined with treadmill training or a sham procedure with treadmill training daily over a two-week period.
Eligibility
Inclusion Criteria:
- Confirmation of Stroke by digital or physical imaging or medical report
- Gait impairment
- Stroke with at least 6 months after ictus
Exclusion Criteria:
- Metallic implants in spinal cord
- Major orthopedic/rheumatological disorders
- Inability of verbal or non-verbal communication